Simone Perazzolo

Last updated

Simone Perazzolo
Born
Verona, Italy
Known for• Development of SAAM II software • Modeling of long-acting injectable antiretrovirals
AwardsJournal of Pharmaceutical Sciences Outstanding Scientist Award (2022, 2024)
Scientific career
FieldsPharmacokinetics, Physiologically-based pharmacokinetic modeling, Compartmental modeling
InstitutionsUniversity of Washington
Nanomath LLC

Simone Perazzolo is an Italian-British pharmacokineticist and software developer known for his work on physiologically-based and compartmental modeling of long-acting injectable drugs for HIV and other infectious diseases, and for maintaining the SAAM II kinetic modeling software. [1] [2]

Perazzolo is affiliated with the Department of Pharmaceutics at the University of Washington in Seattle and is the founder and director of Nanomath LLC, which has distributed and further developed SAAM II since 2022. [3]

Awards

References

  1. 1 2 Perazzolo, Simone (February 2023). "Outstanding Scientist Award 2022". Journal of Pharmaceutical Sciences. 112 (2): 357. doi:10.1016/j.xphs.2022.11.019.
  2. 1 2 Perazzolo, Simone (November 2024). "Outstanding Scientist Award 2024". Journal of Pharmaceutical Sciences. 114 (2): 641. doi:10.1016/j.xphs.2024.11.010.
  3. ↑ Perazzolo, Simone (August 2024). "SAAM II: A general mathematical modeling rapid prototyping environment". CPT: Pharmacometrics & Systems Pharmacology. 13 (8): 1088–1102. doi:10.1002/psp4.13181. PMC   11247119 . PMID   38863172.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.